Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ultralife (ULBI) Equity Average (2016 - 2025)

Historic Equity Average for Ultralife (ULBI) over the last 14 years, with Q3 2025 value amounting to $138.0 million.

  • Ultralife's Equity Average rose 302.42% to $138.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.0 million, marking a year-over-year increase of 302.42%. This contributed to the annual value of $129.8 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Ultralife's Equity Average stood at $138.0 million, which was up 302.42% from $137.6 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Equity Average ranged from a high of $138.0 million in Q3 2025 and a low of $117.4 million during Q1 2021
  • For the 4-year period, Ultralife's Equity Average averaged around $126.6 million, with its median value being $125.4 million (2023).
  • Its Equity Average has fluctuated over the past 5 years, first surged by 1110.26% in 2024, then surged by 302.42% in 2025.
  • Quarter analysis of 4 years shows Ultralife's Equity Average stood at $118.9 million in 2021, then grew by 3.95% to $123.6 million in 2023, then increased by 8.75% to $134.4 million in 2024, then increased by 2.7% to $138.0 million in 2025.
  • Its Equity Average stands at $138.0 million for Q3 2025, versus $137.6 million for Q2 2025 and $135.4 million for Q1 2025.